ScholarIQanswers from OpenAlex
Enzo Life Sciences (United States)
InstitutionResearch output, impact & collaborations
Enzo Life Sciences (United States) is a institution indexed in ScholarIQ from OpenAlex.
What is known about Enzo Life Sciences (United States)?
ScholarIQrecord summary
Enzo Life Sciences (United States) is a research organisation in Farmingdale, US. OpenAlex records 1,191 works and 890,832 citations for it. 489 researchers list it as their most recent affiliation.
How many works does Enzo Life Sciences (United States) have?
ScholarIQindexed works
Enzo Life Sciences (United States) has 1,191 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Enzo Life Sciences (United States) have?
ScholarIQcitation count
Enzo Life Sciences (United States) has 890,832 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Enzo Life Sciences (United States)?
ScholarIQresearcher count
Enzo Life Sciences (United States) has 489 researchers in the ScholarIQ index.
What is the average h-index at Enzo Life Sciences (United States)?
ScholarIQavg h-index
Enzo Life Sciences (United States) has an average h-index of 55.8 in OpenAlex.
What is the ROR of Enzo Life Sciences (United States)?
ScholarIQror
The ROR for Enzo Life Sciences (United States) is on the source record.
What is the OpenAlex record for Enzo Life Sciences (United States)?
ScholarIQopenalex
The OpenAlex for Enzo Life Sciences (United States) is on the source record.
Who are the most-cited researchers behind Enzo Life Sciences (United States)?
ScholarIQtop researchers by citations
What are the most-cited papers on Enzo Life Sciences (United States)?
ScholarIQmost cited works
A Draft Sequence of the Neandertal Genome
Richard E. Green, Johannes Krause, Adrian W. Briggs, Tomislav Maričić, Udo Stenzel, Martin Kircher, Nick Patterson, Heng Li, Weiwei Zhai, Markus Hsi-Yang Fritz, Nancy F. Hansen, Éric Durand, Anna‐Sapfo Malaspinas, Jeffrey D. Jensen, Tomàs Marquès‐Bonet, Can Alkan, Kay Prüfer, Matthias Meyer, Hernán A. Burbano, Jeffrey M. Good, Rigo Schultz, Ayinuer Aximu‐Petri, Anne Butthof, Barbara Höber, Barbara Höffner, Madlen Siegemund, Antje Weihmann, Chad Nusbaum, Eric S. Lander, Carsten Russ, Nathaniel Novod, Jason P. Affourtit, Michael Egholm, Christine Verna, Pavao Rudan, Dejana Brajković, Željko Kućan, Ivan Gušić, Vladimir B. Doronichev, Liubov V. Golovanova, Carles Lalueza‐Fox, Marco de la Rasilla Vives, Javier Fortea, Antonio Rosas, Ralf W. Schmitz, Philip L. Johnson, Evan E. Eichler, Daniel Falush, Ewan Birney, James C. Mullikin, Montgomery Slatkin, Rasmus Nielsen, Janet Kelso, Michael Lachmann, David Reich, Svante Pääbo
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Eunice L. Kwak, Yung‐Jue Bang, D. Ross Camidge, Alice T. Shaw, Benjamin Solomon, Robert G. Maki, Sai‐Hong Ignatius Ou, Bruce J. Dezube, Pasi A. Jänne, Daniel B. Costa, Marileila Varella‐Garcia, Woo Ho Kim, Thomas J. Lynch, Panos Fidias, Hannah Stubbs, Jeffrey A. Engelman, Lecia V. Sequist, Weiwei Tan, Leena Gandhi, Mari Mino–Kenudson, Greg C. G. Wei, S. Martin Shreeve, Mark J. Ratain, Jeffrey Settleman, James G. Christensen, Daniel A. Haber, Keith D. Wilner, Ravi Salgia, Geoffrey I. Shapiro, Jeffrey W. Clark, A. John Iafrate
Systematic identification of genomic markers of drug sensitivity in cancer cells
Mathew J. Garnett, Elena J. Edelman, Sonja J. Heidorn, Chris Greenman, Anahita Dastur, King Wai Lau, Patricia Greninger, I. Richard Thompson, Xi Luo, Jorge Soares, Qingsong Liu, Francesco Iorio, Didier Surdez, Li Chen, Randy Milano, Graham R. Bignell, Ah Ting Tam, Helen Davies, Jesse A. Stevenson, Syd Barthorpe, Stephen Lutz, Fiona Kogera, Karl Lawrence, Anne McLaren-Douglas, Xeni Mitropoulos, Tatiana Mironenko, Helen Thi, Laura Richardson, Wenjun Zhou, Frances Jewitt, Tinghu Zhang, Patrick O’Brien, Jessica L. Boisvert, Stacey Price, Wooyoung Hur, Wanjuan Yang, Xianming Deng, Adam P. Butler, Hwan Geun Choi, Jae Won Chang, José Baselga, Ivan Stamenkovic, Jeffrey A. Engelman, Sreenath V. Sharma, Olivier Delattre, Julio Sáez-Rodríguez, Nathanael S. Gray, Jeffrey Settleman, P. Andrew Futreal, Daniel A. Haber, Michael R. Stratton, Sridhar Ramaswamy, Ultan McDermott, Cyril H. Benes
Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor <i>EML4-ALK</i>
Alice T. Shaw, Beow Y. Yeap, Mari Mino–Kenudson, Subba R. Digumarthy, Daniel B. Costa, Rebecca S. Heist, Benjamin Solomon, Hannah Stubbs, Sonal Admane, Ultan McDermott, Jeffrey Settleman, Susumu Kobayashi, Eugene J. Mark, Scott J. Rodig, Lucian R. Chirieac, Eunice L. Kwak, Thomas J. Lynch, A. John Iafrate
Detection of Mutations in <i>EGFR</i> in Circulating Lung-Cancer Cells
Shyamala Maheswaran, Lecia V. Sequist, Sunitha Nagrath, Lindsey Ulkus, Brian W. Brannigan, Chey V. Collura, Elizabeth K. Inserra, Sven Diederichs, A. John Iafrate, Daphne W. Bell, Subba R. Digumarthy, Alona Muzikansky, Daniel Irimia, Jeffrey Settleman, Ronald G. Tompkins, Thomas J. Lynch, Mehmet Toner, Daniel A. Haber
How much of the research on Enzo Life Sciences (United States) is open access?
ScholarIQopen access share
82%OPEN ACCESS